Last Price
0.507
Today's Change
-0.012 (2.30%)
Day's Change
0.481 - 0.52
Trading Volume
35,647
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Joseph Edward Tucker Ph.D. Dr. Joseph Edward Tucker Ph.D.
Full Time Employees: 7 7
IPO Date: 2015-05-04 2015-05-04
CIK: 0000890821 0000890821
ISIN: US29405E2081 US29405E2081
CUSIP: 29405E208 29405E208
Beta: 0.50 0.50
Last Dividend: 0.00 0.00
Dcf Diff: -0.55 -0.55
Dcf: 1.06 1.06
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.